View in EDS HTML Full Text PDF Full Text

Novel Potent and Selective Dopamine D4 Receptor Piperidine Antagonists as Potential Alternatives for the Treatment of Glioblastoma.

Saved in:
Bibliographic Details
Title: Novel Potent and Selective Dopamine D4 Receptor Piperidine Antagonists as Potential Alternatives for the Treatment of Glioblastoma.
Authors: Matteucci F; Medicinal Chemistry Unit, School of Pharmacy, Chemistry Interdisciplinary Project (ChIP), University of Camerino, 62032 Camerino, Italy., Pavletić P; Medicinal Chemistry Unit, School of Pharmacy, Chemistry Interdisciplinary Project (ChIP), University of Camerino, 62032 Camerino, Italy.; Faculty of Biotechnology and Drug Development, University of Rijeka, 51000 Rijeka, Croatia., Bonifazi A; Department of Pharmacology and Toxicology, Center for Addiction Sciences and Therapeutics, University of Texas Medical Branch, Galveston, TX 77555, USA., Garland R; Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, Bouvé College of Health Sciences, Center for Drug Discovery, Northeastern University, Boston, MA 02115, USA., Yano H; Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, Bouvé College of Health Sciences, Center for Drug Discovery, Northeastern University, Boston, MA 02115, USA., Amantini C; Immunopathology and Molecular Medicine Unit, School of Biosciences and Veterinary Medicine, University of Camerino, 62032 Camerino, Italy., Zeppa L; Immunopathology and Molecular Medicine Unit, School of Biosciences and Veterinary Medicine, University of Camerino, 62032 Camerino, Italy., Sabato E; Department of Pharmaceutical Sciences, University of Milan, 20133 Milano, Italy., Vistoli G; Department of Pharmaceutical Sciences, University of Milan, 20133 Milano, Italy., Mammoli V; Center for Drug Discovery and Development-IDD, Aptuit, an Evotec Company, 37135 Verona, Italy., Cappellacci L; Medicinal Chemistry Unit, School of Pharmacy, Chemistry Interdisciplinary Project (ChIP), University of Camerino, 62032 Camerino, Italy., Del Bello F; Medicinal Chemistry Unit, School of Pharmacy, Chemistry Interdisciplinary Project (ChIP), University of Camerino, 62032 Camerino, Italy., Giorgioni G; Medicinal Chemistry Unit, School of Pharmacy, Chemistry Interdisciplinary Project (ChIP), University of Camerino, 62032 Camerino, Italy., Petrelli R; Medicinal Chemistry Unit, School of Pharmacy, Chemistry Interdisciplinary Project (ChIP), University of Camerino, 62032 Camerino, Italy., Piergentili A; Medicinal Chemistry Unit, School of Pharmacy, Chemistry Interdisciplinary Project (ChIP), University of Camerino, 62032 Camerino, Italy., Quaglia W; Medicinal Chemistry Unit, School of Pharmacy, Chemistry Interdisciplinary Project (ChIP), University of Camerino, 62032 Camerino, Italy., Piergentili A; Medicinal Chemistry Unit, School of Pharmacy, Chemistry Interdisciplinary Project (ChIP), University of Camerino, 62032 Camerino, Italy.
Source: Pharmaceuticals (Basel, Switzerland) [Pharmaceuticals (Basel)] 2025 May 17; Vol. 18 (5). Date of Electronic Publication: 2025 May 17.
Publication Type: Journal Article
Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101238453 Publication Model: Electronic Cited Medium: Print ISSN: 1424-8247 (Print) Linking ISSN: 14248247 NLM ISO Abbreviation: Pharmaceuticals (Basel) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40430557
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Novel Potent and Selective Dopamine D4 Receptor Piperidine Antagonists as Potential Alternatives for the Treatment of Glioblastoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Matteucci+F%22">Matteucci F</searchLink>; Medicinal Chemistry Unit, School of Pharmacy, Chemistry Interdisciplinary Project (ChIP), University of Camerino, 62032 Camerino, Italy.<br /><searchLink fieldCode="AU" term="%22Pavletić+P%22">Pavletić P</searchLink>; Medicinal Chemistry Unit, School of Pharmacy, Chemistry Interdisciplinary Project (ChIP), University of Camerino, 62032 Camerino, Italy.; Faculty of Biotechnology and Drug Development, University of Rijeka, 51000 Rijeka, Croatia.<br /><searchLink fieldCode="AU" term="%22Bonifazi+A%22">Bonifazi A</searchLink>; Department of Pharmacology and Toxicology, Center for Addiction Sciences and Therapeutics, University of Texas Medical Branch, Galveston, TX 77555, USA.<br /><searchLink fieldCode="AU" term="%22Garland+R%22">Garland R</searchLink>; Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, Bouvé College of Health Sciences, Center for Drug Discovery, Northeastern University, Boston, MA 02115, USA.<br /><searchLink fieldCode="AU" term="%22Yano+H%22">Yano H</searchLink>; Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, Bouvé College of Health Sciences, Center for Drug Discovery, Northeastern University, Boston, MA 02115, USA.<br /><searchLink fieldCode="AU" term="%22Amantini+C%22">Amantini C</searchLink>; Immunopathology and Molecular Medicine Unit, School of Biosciences and Veterinary Medicine, University of Camerino, 62032 Camerino, Italy.<br /><searchLink fieldCode="AU" term="%22Zeppa+L%22">Zeppa L</searchLink>; Immunopathology and Molecular Medicine Unit, School of Biosciences and Veterinary Medicine, University of Camerino, 62032 Camerino, Italy.<br /><searchLink fieldCode="AU" term="%22Sabato+E%22">Sabato E</searchLink>; Department of Pharmaceutical Sciences, University of Milan, 20133 Milano, Italy.<br /><searchLink fieldCode="AU" term="%22Vistoli+G%22">Vistoli G</searchLink>; Department of Pharmaceutical Sciences, University of Milan, 20133 Milano, Italy.<br /><searchLink fieldCode="AU" term="%22Mammoli+V%22">Mammoli V</searchLink>; Center for Drug Discovery and Development-IDD, Aptuit, an Evotec Company, 37135 Verona, Italy.<br /><searchLink fieldCode="AU" term="%22Cappellacci+L%22">Cappellacci L</searchLink>; Medicinal Chemistry Unit, School of Pharmacy, Chemistry Interdisciplinary Project (ChIP), University of Camerino, 62032 Camerino, Italy.<br /><searchLink fieldCode="AU" term="%22Del+Bello+F%22">Del Bello F</searchLink>; Medicinal Chemistry Unit, School of Pharmacy, Chemistry Interdisciplinary Project (ChIP), University of Camerino, 62032 Camerino, Italy.<br /><searchLink fieldCode="AU" term="%22Giorgioni+G%22">Giorgioni G</searchLink>; Medicinal Chemistry Unit, School of Pharmacy, Chemistry Interdisciplinary Project (ChIP), University of Camerino, 62032 Camerino, Italy.<br /><searchLink fieldCode="AU" term="%22Petrelli+R%22">Petrelli R</searchLink>; Medicinal Chemistry Unit, School of Pharmacy, Chemistry Interdisciplinary Project (ChIP), University of Camerino, 62032 Camerino, Italy.<br /><searchLink fieldCode="AU" term="%22Piergentili+A%22">Piergentili A</searchLink>; Medicinal Chemistry Unit, School of Pharmacy, Chemistry Interdisciplinary Project (ChIP), University of Camerino, 62032 Camerino, Italy.<br /><searchLink fieldCode="AU" term="%22Quaglia+W%22">Quaglia W</searchLink>; Medicinal Chemistry Unit, School of Pharmacy, Chemistry Interdisciplinary Project (ChIP), University of Camerino, 62032 Camerino, Italy.<br /><searchLink fieldCode="AU" term="%22Piergentili+A%22">Piergentili A</searchLink>; Medicinal Chemistry Unit, School of Pharmacy, Chemistry Interdisciplinary Project (ChIP), University of Camerino, 62032 Camerino, Italy.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101238453%22">Pharmaceuticals (Basel, Switzerland)</searchLink> [Pharmaceuticals (Basel)] 2025 May 17; Vol. 18 (5). <i>Date of Electronic Publication: </i>2025 May 17.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22MDPI%22">MDPI </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101238453 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>1424-8247 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214248247%22">14248247 </searchLink><i>NLM ISO Abbreviation: </i>Pharmaceuticals (Basel) <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40430557
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3390/ph18050739
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Novel Potent and Selective Dopamine D4 Receptor Piperidine Antagonists as Potential Alternatives for the Treatment of Glioblastoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Matteucci F
      – PersonEntity:
          Name:
            NameFull: Pavletić P
      – PersonEntity:
          Name:
            NameFull: Bonifazi A
      – PersonEntity:
          Name:
            NameFull: Garland R
      – PersonEntity:
          Name:
            NameFull: Yano H
      – PersonEntity:
          Name:
            NameFull: Amantini C
      – PersonEntity:
          Name:
            NameFull: Zeppa L
      – PersonEntity:
          Name:
            NameFull: Sabato E
      – PersonEntity:
          Name:
            NameFull: Vistoli G
      – PersonEntity:
          Name:
            NameFull: Mammoli V
      – PersonEntity:
          Name:
            NameFull: Cappellacci L
      – PersonEntity:
          Name:
            NameFull: Del Bello F
      – PersonEntity:
          Name:
            NameFull: Giorgioni G
      – PersonEntity:
          Name:
            NameFull: Petrelli R
      – PersonEntity:
          Name:
            NameFull: Piergentili A
      – PersonEntity:
          Name:
            NameFull: Quaglia W
      – PersonEntity:
          Name:
            NameFull: Piergentili A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 17
              M: 05
              Text: 2025 May 17
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 1424-8247
          Numbering:
            – Type: volume
              Value: 18
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Pharmaceuticals (Basel, Switzerland)
              Type: main
ResultId 1